COPY Q1 2017 10-Q

Copytele Inc (COPY) SEC Quarterly Report (10-Q) for Q2 2017

COPY Q3 2017 10-Q
COPY Q1 2017 10-Q COPY Q3 2017 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 30, 2017

Commission file number 0-11254

ITUS Corporation

(Exact name of registrant as specified in its charter)

                     Delaware                         11-2622630

       (State or other jurisdiction of                                                                                                                    (I.R.S. Employer

         incorporation or organization)                                                                                                                   Identification No.)

                                   12100 Wilshire Boulevard, Suite 1275                                                                                                                                                  

Los Angeles, CA                                                                                                         90025

(Address of principal executive offices)                                                                                                                  (Zip Code)

(310) 484-5200

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   X            No ___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes   X            No ___

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "non-accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [   ]

Accelerated filer [   ]

Non-accelerated filer   [   ]  (Do not check if a smaller reporting company)

Smaller reporting company [X]

Emerging growth company   [   ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   [   ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ____         No   X  

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

On May 25, 2017, the registrant had outstanding 15,120,239 shares of Common Stock, par value $.01 per share, which is the registrant's only class of common stock.           


TABLE OF CONTENTS

PART I.  FINANCIAL INFORMATION

Item 1.

Financial Statements.

Condensed Consolidated Balance Sheets as of April 30, 2017 (Unaudited) and October 31, 2016

3

Condensed Consolidated Statements of Operations (Unaudited) for the six months ended April 30, 2017 and 2016

4

Condensed Consolidated Statements of Operations (Unaudited) for the three months ended April 30, 2017 and 2016 

5

Condensed Consolidated Statement of Shareholders' Equity (Unaudited) for the six months ended April 30 2017

6

Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended April 30, 2017 and 2016

7

Notes to Condensed Consolidated Financial Statements (Unaudited)

8

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

26

Item 4.

Controls and Procedures.

26

PART II.  OTHER INFORMATION

Item 1.

Legal Proceedings.

27

Item 1A.

Risk Factors.

27

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

27

Item 3.

Defaults Upon Senior Securities.

27

Item 4.

Mine Safety Disclosures.

27

Item 5.

Other Information.

27

Item 6.

Exhibits.

27

SIGNATURES

28

2


Table of Contents

PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements.

ITUS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

April 30,
 2017

October 31,

2016

ASSETS

Current assets:

Cash and cash equivalents

$

2,876,897

$

2,488,323

Short-term investments in certificates of deposit

2,250,000

750,000

Prepaid expenses and other current assets

64,647

162,069

Total current assets

5,191,544

3,400,392

Patents, net of accumulated amortization of $1,127,688 and $965,040, respectively

1,908,423

2,071,071

Property and equipment, net of accumulated depreciation of $68,228 and 
    $46,950, respectively

149,487

156,644

Total assets

$

7,249,454

$

5,628,107

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable and accrued expenses

$

660,023

$

468,756

Secured debenture (Note 7)

3,000,000

-

Total current liabilities

3,660,023

468,756

Patent acquisition obligation

-

4,171,876

Total liabilities

3,660,023

4,640,632

Commitments and contingencies (Note 11)

Shareholders' equity:

Preferred stock, par value $100 per share; 19,860 shares authorized; no
    shares issued or outstanding

-

-

Series A convertible preferred stock, par value $100 per share; 140 shares
    authorized; -0- and 140 shares issued and outstanding, respectively

-

14,000

Common stock, par value $.01 per share; 24,000,000 shares authorized;
   11,694,863 and 8,752,387 shares issued and outstanding, respectively

116,949

87,524

Additional paid-in capital

156,066,446

152,051,144

Accumulated deficit

(152,593,964)

(151,165,193)

Total shareholders' equity

3,589,431

987,475

Total liabilities and shareholders' equity

$

7,249,454

$

5,628,107

The accompanying notes are an integral part of these condensed consolidated financial statements.